Bristol-Myers Squibb
BMY
#178
Rank
A$188.19 B
Marketcap
A$92.13
Share price
0.49%
Change (1 day)
30.74%
Change (1 year)

EPS for Bristol-Myers Squibb (BMY)

EPS in 2026 (TTM): A$5.29

According to Bristol-Myers Squibb's latest financial reports the company's current EPS (TTM) is A$5.04. In 2025 the company made an earnings per share (EPS) of A$4.90 an increase over its 2024 EPS that were of A-$6.26.

EPS history for Bristol-Myers Squibb from 2012 to 2026

Annual EPS

Year EPS Change
2026 (TTM)A$5.297.95%
2025A$4.90-178.28%
2024A-$6.26-213.92%
2023A$5.5030.2%
2022A$4.22-6.04%
2021A$4.49-179.29%
2020A-$5.67-281.37%
2019A$3.12-27.21%
2018A$4.29
2016A$3.78175.26%
2015A$1.37-19.83%
2014A$1.71-22.44%
2013A$2.2134.48%
2012A$1.64

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
A$12.37 145.36%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
A$9.94 97.19%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
A$1.86-63.20%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
A$2.91-42.22%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
A$39.98 692.85%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
A$20.51 306.74%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
A$3.63-28.10%๐Ÿ‡ซ๐Ÿ‡ท France
Biogen
BIIB
A$13.24 162.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
A$5.06 0.42%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
A$9.84 95.22%๐Ÿ‡ฌ๐Ÿ‡ง UK